HistoRx Targets Drug Development With New Tissue Imaging System
This article was originally published in The Pink Sheet Daily
Executive Summary
Four pharmacogenetic genetic tests, including one for melanoma and one to detect a patient’s response to Genentech’s Herceptin, are in HistoRx’ pipeline.